Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping

NCT00558311 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1157

Enrollment

INDUSTRY

Sponsor class

Conditions

Aneurysmal Subarachnoid Hemorrhage

Interventions

DRUG: Clazosentan
DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.